Treatment of insomnia in older adults: Re-evaluating the benefits and risks of sedative hypnotic agents

Journal of Gerontological Nursing

Volumn 39, Issue 4, 2013, Pages 48-54

  Brandt, Nicole J ^a   Piechocki, Jennifer M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT;

AGED; ARTICLE; CLASSIFICATION; GERIATRIC NURSING; HUMAN; INSOMNIA; RISK ASSESSMENT;

AGED; GERIATRIC NURSING; HUMANS; HYPNOTICS AND SEDATIVES; RISK ASSESSMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS;

MLCS; MLOWN;

EID: 84879730490     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20130220-99     Document Type: Article

References (29)

1. Agostini, J.V., Leo-Summers, L.S., & Inouye, S.K. (2001). Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Archives of Internal Medicine, 161, 2091-2097.
2. Allain, H., Bentué-Ferrer, D., Polard, E., Akwa, Y., & Patat, A. (2005). Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: A comparative review. Drugs & Aging, 22, 749-765.
3. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60, 616-631.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
5. Avidan, A.Y., Palmer, L.A., Doan, J.F., & Baran, R.W. (2010). Insomnia medication use and the probability of an accidental event in an older adult population. Drug, Healthcare and Patient Safety, 2, 225-232. doi:10.2147/DHPS. S14955
6. Basu, R., Dodge, H., Stoehr, G.P., & Ganguli, M. (2003). Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: Effects on cognition. American Journal of Psychiatry, 11, 205-213.
7. Billioti de Gage, S., Bégaud, B., Bazin, F., Verdoux, H., Dartigues, J.F., Pérès, K., Pariente, A. (2012). Benzodiazepine use and risk of dementia: Prospective population based study. BMJ, 345, e6231. doi:10.1136/bmj.e6231
8. Bloom, H.G., Ahmed I., Alessi, C.A., Ancoli- Israel, S., Buysse, D.J., Kryger, M.H.,.. Zee, P.C. (2009). Evidence-based recommendations for the assessment and management of sleep disorders in older persons. Journal of the American Geriatrics Society, 57, 761-789.
9. Crowley, K. (2011). Sleep and sleep disorders in older adults. Neuropsychology Review, 21, 41-53. doi:10.1007/s11065-010-9154-6
10. Darowski, A., Chambers, S.A., & Chambers, D.J. (2009). Antidepressants and falls in the elderly. Drugs & Aging, 26, 381-394. doi:10.2165/00002512- 200926050-00002
11. Dolder, C., Nelson, M., & McKinsey, J. (2007). Use of non-benzodiazepine hypnotics in the elderly: Are all agents the same? CNS Drugs, 21, 389-405.
12. Finkle, W.D., Der, J.S., Greenland, S., Adams, J.L., Ridgeway, G., Blaschke, T., & VanRiper, K.B. (2011). Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. Journal of the American Geriatrics Society, 59, 1883-1890. doi:10.1111/j.1532- 5415.2011.03591.x
13. Frey, D.J., Ortega, J.D., Wiseman, C., Farley, C.T., & Wright, K.P., Jr. (2011). Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: A randomized placebo-controlled trial. Journal of the American Geriatrics Society, 59, 73-81. doi:10.1111/j.1532- 5415.2010.03229.x
14. Glass, J., Lanctôt, K.L., Herrmann, N., Sproule, B.A., & Busto, U.E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ, 331, 1169.
15. Huang, Y.S., Hsu, S.C., Liu, S.I., & Chen, C.K. (2011). A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. Chang Gung Medical Journal, 34, 50-56.
16. Kang, D.Y., Park, S., Rhee, C.W., Kim, Y.J., Choi, N.K., Lee, J., & Park, B.J. (2012). Zolpidem use and risk of fracture in elderly insomnia patients. Journal of Preventative Medicine and Public Health, 45, 219- 226. doi:10.3961/jpmph.2012.45.4.219
17. Lemoine, P., Garfinkel, D., Nir, T., & Zisapel, N. (2011). Prolonged-release melatonin for insomnia-An open-label long-term study of efficacy, safety, and withdrawal. Therapeutics and Clinical Risk Management, 7, 301-311. doi:10.2147/TCRM. S23036
18. Leppik, I., Roth-Schechter, G., Gray, G., Cohn, M., & Owens, D. (1997). Doubleblind, placebo-controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia. Drug Development Research, 40, 230-238.
19. Lexicomp Online. (2012). Lexi-Comp Online . Retrieved from http://online.lexi. com.proxy-hs.researchport.umd.edu.
20. Maglione, M., Maher, A.R., Hu, J., Wang, Z., Shanman, R., Shekelle P.G.,Perry, T. (2011). Off-label use of atypical antipsychotics: An update. AHRQ Comparative Effectiveness Reviews, Report No. 11-EHC087-EF. Retrieved from http:// effectivehealthcare.ahrq.gov/index.cfm/ search-for-guides-reviews-and-reports/? productid=786&pageaction=displaypro duct
21. Maher, A.R., & Theodore, G. (2012). Summary of the comparative effectiveness review of off-label use of atypical antipsychotics. Journal of Managed Care Pharmacy, 18(5 Suppl. B), S1-S20.
22. Mayer, G., Wang-Weigand, S., Roth- Schechter, B., Lehmann, R., Staner, C., & Partinen, M. (2009). Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep, 32, 351-360.
23. McCall, W.V. (2005). Diagnosis and management of insomnia in older people. Journal of the American Geriatrics Society, 53(7 Suppl.), S272-S277.
24. Morin, C.M., Bastien, C., Guay, B., Radouco- Thomas, M., Leblanc, J., & Vallieres, A. (2004). Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. American Journal of Psychiatry, 161, 332-342.
25. Orriols, L., Philip, P., Moore, N., Castot, A., Gadegbeku, B., Delorme, B., & Lagarde, E. (2011). Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clinical Pharmacology and Therapeutics, 89, 595-601.
26. Paterniti, S., Dufouil, C., & Alperovitch, A. (2002). Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study. Journal of Clinical Psychopharmacology, 22, 285-293.
27. Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008). Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of Clinical Sleep Medicine, 4, 487-504.
28. Tassniyom, K., Paholpak, S., Tassniyom, S., & Kiewyoo, J. (2010). Quetiapine for primary insomnia: A double blind, randomized clinical controlled trial. Journal of the Medical Association of Thailand, 93, 729-734.
29. Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J., & Roth, T. (2007). Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. Journal of Clinical Sleep Medicine, 3, 495-504